{"id":"scopolamine-transdermal-patch-transderm-scop","safety":{"commonSideEffects":[{"rate":"10-30%","effect":"Dry mouth"},{"rate":"5-15%","effect":"Dizziness"},{"rate":"5-15%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"2-5%","effect":"Confusion"}]},"_chembl":{"chemblId":"CHEMBL569713","moleculeType":"Small molecule","molecularWeight":"303.36"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This blockade results in decreased parasympathetic activity, leading to reduced salivation, bronchial secretions, and gastrointestinal motility. Additionally, scopolamine's central effects can cause drowsiness, confusion, and amnesia.","oneSentence":"Scopolamine acts as a muscarinic acetylcholine receptor antagonist, blocking the action of acetylcholine at muscarinic receptors in the central and peripheral nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:33:42.401Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of motion sickness"},{"name":"Treatment of postoperative nausea and vomiting"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TDS, Patch"],"phase":"phase_3","status":"active","brandName":"Scopolamine Transdermal Patch [Transderm Scop]","genericName":"Scopolamine Transdermal Patch [Transderm Scop]","companyName":"Naval Aeromedical Research Unit, Dayton","companyId":"naval-aeromedical-research-unit-dayton","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Scopolamine acts as a muscarinic acetylcholine receptor antagonist, blocking the action of acetylcholine at muscarinic receptors in the central and peripheral nervous system. Used for Prevention of motion sickness, Treatment of postoperative nausea and vomiting.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}